Klacid Baby

Clarithromycin, the active ingredient in Klacid Baby, is a macrolide antibiotic presented as an oral suspension for pediatric use. It treats bacterial infections of the respiratory tract, ears, sinuses, skin and soft tissues in children and is formulated for easy administration to infants and young children, providing reliable systemic exposure.

GNH USA supplies Klacid Baby as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is used to treat bacterial infections affecting several organ systems in pediatric patients.

- Respiratory tract infections: effective against common bacterial pathogens causing pneumonia and bronchitis in children. - Skin and soft tissue infections: eradicates susceptible Staphylococcus and Streptococcus species in cellulitis and wound infections. - Otitis media: clears bacterial ear infections that lead to pain and hearing loss. - Sinusitis: resolves acute bacterial sinus inflammation. - Bacterial pneumonia: treats community‑acquired pneumonia caused by susceptible organisms.

Clarithromycin may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools that may be watery. - Abdominal pain: cramping or discomfort in the stomach area.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): rapid onset of hives, swelling, or breathing difficulty. - Clostridioides difficile‑associated diarrhea: severe colitis with watery stools. - Liver enzyme elevation: signs of hepatotoxicity such as jaundice. - QT prolongation: potential cardiac rhythm disturbances that may lead to arrhythmia.

When prescribing clarithromycin, clinicians should consider several safety measures.

- Assess renal function: adjust dose in severe impairment. - Monitor liver enzymes: watch for hepatotoxicity during therapy. - Avoid use in patients with known macrolide hypersensitivity. - Consider ECG monitoring: risk of QT interval prolongation. - Store at ambient temperature: keep in the original pack, protect from moisture.

Clarithromycin interacts with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole): may increase clarithromycin concentrations. - Cisapride: risk of serious cardiac arrhythmia. - Ergot alkaloids: may precipitate ergotism.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect; monitor INR. - Theophylline: may raise serum levels; observe for toxicity.